The Trial Innovation Network (TIN) is a platform for multi-center trials and studies that encompass a wide-range of disciplines. Investigators do not need to apply for a specific RFA, but should propose a multi-center trial or study. The Network will prioritize proposals for multi-center clinical trials and studies with patient-oriented endpoints with potential for impact on clinical practice and operational innovation as well as proposals that foster collaborations with other NIH ICs over proposals seeking funding from NCATS.

Researchers are welcome to request access to the N3C Data Enclave, one of the largest, most secure clinical data resources for accelerating and collaborating on COVID-19 research.

The Data2Discovery Gateway Special Interest Groups highlights a number of resources and services for analysis and use of patient data, including several external research enclaves.

The All of Us Research Program is a large-scale study that aims to improve health by gathering data from a diverse group of people in the United States. The program is part of the National Institutes of Health's (NIH) Precision Medicine Initiative.

The NCATS ENACT Network, which stands for 'Evolve to Next-Gen ACT' Network, is a platform that allows researchers to query de-identified electronic health record (EHR) data across a consortium of institutions. Request Access via email: researchdata@uabmc.edu

TriNetX Research datasets provide researchers access to de-identified patient data from a network of health care organizations. TriNetX datasets include clinical patient data such as demographics, diagnoses, procedures, labs and medications - commonly referred to as real-world data. Request access via email: researchdata@uabmc.edu

OneFlorida+ is a collaboration among researchers, clinicians and patients that provides a venue for pragmatic clinical trials, comparative effectiveness research, implementation science studies, observational research, and cohort discovery for a wide range of research. OneFlorida+ is part of the National Patient Centered Clinical Research Network.

The Alabama Genomic Health Initiative is one of the nation's first statewide efforts to harness the power of genomic analysis in helping identify those who are at risk for diseases for genomic abnormalities.

AGHI Leadership includes members from UAB, HudsonAlpha Institute for Biotechnology and Tuskegee University, nationally recognized institutions that are leaders in bioethics and genomic medicine.